ALLEN, Texas, Nov. 09, 2018 (GLOBE NEWSWIRE) -- Atrion Corporation ATRI today announced that for the third quarter ended September 30, 2018 revenues totaled $39.3 million, up from $37.9 million for the same period in 2017. Net income for the third quarter of 2018 totaled $9.2 million compared to $8.0 million for the third quarter of 2017, with diluted earnings per share for the third quarter of 2018 at $4.96 compared to $4.29 for the same period in 2017.
Commenting on the Company's results for the third quarter of 2018 compared to the same period last year, David A. Battat, President & CEO, said, "Aggregate revenue growth in all product lines excluding Ophthalmology was up 6%. The overall revenue growth of 4% was achieved despite a 23% decline in Ophthalmology as we are winding down certain products with contract and intellectual property expirations. This headwind will continue to impact our comparisons until the end of the first quarter of 2019. Net income and diluted EPS were both up 16% compared to last year's third quarter." Mr. Battat concluded, "During the quarter we added $4.3 million to our cash and short and long term investments bringing the total to $87 million as of September 30, 2018. We continue to be debt free."
Atrion Corporation develops and manufactures products primarily for medical applications. The Company's website is www.atrioncorp.com.
Statements in this press release that are forward looking are based upon current expectations and actual results or future events may differ materially. Such statements include, but are not limited to, Atrion's expectations regarding the headwind from Ophthalmology sales until the end of the first quarter of 2019. Words such as "expects," "believes," "anticipates," "intends," "should", "plans," "will" and variations of such words and similar expressions are intended to identify such forward-looking statements. Forward-looking statements involve risks and uncertainties. The following are some of the factors that could cause actual results or future events to differ materially from those expressed in or underlying our forward-looking statements: changing economic, market and business conditions; acts of war or terrorism; the effects of governmental regulation; competition and new technologies; slower-than-anticipated introduction of new products or implementation of marketing strategies; the Company's ability to protect its intellectual property; changes in the prices of raw materials; changes in product mix; and intellectual property and product liability claims and product recalls. The foregoing list of factors is not exclusive, and other factors are set forth in the Company's filings with the Securities and Exchange Commission. The forward-looking statements in this press release are made as of the date hereof, and we do not undertake any obligation, and disclaim any duty, to supplement, update or revise such statements, whether as a result of subsequent events, changed expectations or otherwise, except as required by applicable law.
Contact:
Jeffery Strickland
Vice President and Chief Financial Officer
(972) 390-9800
| ATRION CORPORATION UNAUDITED CONSOLIDATED STATEMENTS OF INCOME (In thousands, except per share data) | |||||||||||||||
| Three Months Ended September 30, | Nine Months Ended September 30, | ||||||||||||||
| 2018 | 2017 | 2018 | 2017 | ||||||||||||
| Revenues | $ | 39,274 | $ | 37,903 | $ | 117,522 | $ | 112,571 | |||||||
| Cost of goods sold | 21,275 | 19,498 | 61,349 | 57,841 | |||||||||||
| Gross profit | 17,999 | 18,405 | 56,173 | 54,730 | |||||||||||
| Operating expenses | 7,242 | 6,926 | 22,784 | 21,749 | |||||||||||
| Operating income | 10,757 | 11,479 | 33,389 | 32,981 | |||||||||||
| Interest and dividend income | 439 | 287 | 1,157 | 806 | |||||||||||
| Other investment income (loss) | 21 | -- | (1,153 | ) | -- | ||||||||||
| Other income | 20 | -- | 20 | 1 | |||||||||||
| Income before income taxes | 11,237 | 11,766 | 33,413 | 33,788 | |||||||||||
| Income tax provision | (2,016 | ) | (3,795 | ) | (6,907 | ) | (5,841 | ) | |||||||
| Net income | $ | 9,221 | $ | 7,971 | $ | 26,506 | $ | 27,947 | |||||||
| Income per basic share | $ | 4.98 | $ | 4.30 | $ | 14.30 | $ | 15.16 | |||||||
| Weighted average basic shares outstanding | 1,853 | 1,852 | 1,853 | 1,844 | |||||||||||
| Income per diluted share | $ | 4.96 | $ | 4.29 | $ | 14.27 | $ | 15.06 | |||||||
| Weighted average diluted shares outstanding | 1,858 | 1,857 | 1,857 | 1,856 | |||||||||||
| ATRION CORPORATION CONSOLIDATED BALANCE SHEETS (In thousands) | |||||
| Sep 30, | Dec. 31, | ||||
| ASSETS | 2018 | 2017 | |||
| (Unaudited) | |||||
| Current assets: | |||||
| Cash and cash equivalents | $ | 50,031 | $ | 30,136 | |
| Short-term investments | 15,465 | 35,468 | |||
| Total cash and short-term investments | 65,496 | 65,604 | |||
| Accounts receivable | 20,766 | 17,076 | |||
| Inventories | 32,172 | 29,354 | |||
| Prepaid expenses and other | 2,599 | 3,199 | |||
| Total current assets | 121,033 | 115,233 | |||
| Long-term investments | 21,166 | 9,136 | |||
| Property, plant and equipment, net | 72,447 | 66,369 | |||
| Other assets | 13,097 | 13,042 | |||
| $ | 227,743 | $ | 203,780 | ||
| LIABILITIES AND STOCKHOLDERS' EQUITY | |||||
| Current liabilities | 11,987 | 9,622 | |||
| Line of credit | -- | -- | |||
| Other non-current liabilities | 10,599 | 9,770 | |||
| Stockholders' equity | 205,157 | 184,388 | |||
| $ | 227,743 | $ | 203,780 | ||
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Date | ticker | name | Actual EPS | EPS Surprise | Actual Rev | Rev Surprise |
|---|
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
